Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 900 participants.
Also called NCT06196047
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 900 participants
- Sponsor
- Registry
-
NCT06196047
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT06196047. Randomized; double masking; primary purpose treatment. Start 2023-12-01 (actual); primary completion 2024-12-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Ticagrelor 90 MG
- Intervention (Drug)
- Cilostazol 100 MG
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06196047- Content hash
a404ba6a3cb7cc0a1fc4c1c7d4433cb9b0cb47b182463b5782f5f57874483206